Open | $2.340 |
Close | $2.310 |
Volume / Avg. | 154.634K / 417.728K |
Day Range | 2.213 - 2.340 |
52 Wk Range | 1.610 - 20.480 |
Market Cap | $238.478M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | % |
Days to Cover | 6.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mesoblast (NASDAQ: MESO) through any online brokerage.
Other companies in Mesoblast’s space includes: bluebird bio (NASDAQ:BLUE), Inovio Pharmaceuticals (NASDAQ:INO), Gritstone Bio (NASDAQ:GRTS), Agenus (NASDAQ:AGEN) and Abeona Therapeutics (NASDAQ:ABEO).
The latest price target for Mesoblast (NASDAQ: MESO) was reported by Cantor Fitzgerald on Thursday, September 21, 2023. The analyst firm set a price target for 17.00 expecting MESO to rise to within 12 months (a possible 623.40% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Mesoblast (NASDAQ: MESO) is $2.35 last updated March 18, 2024 at 5:21 PM EDT.
There are no upcoming dividends for Mesoblast.
Mesoblast’s Q2 earnings are confirmed for Thursday, May 23, 2024.
There is no upcoming split for Mesoblast.
Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.